Curi RMB Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $828K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $307K | Hold |
|
|||||
|
2023
Q1 | $344K | Hold |
|
|||||
|
2022
Q4 | $366K | Buy |
|
|||||
|
2022
Q3 | $288K | Hold |
|
|||||
|
2022
Q2 | $282K | Hold |
|
|||||
|
2022
Q1 | $262K | Hold |
|
|||||
|
2021
Q4 | $300K | Hold |
|
|||||
|
2021
Q3 | $263K | Hold |
|
|||||
|
2021
Q2 | $284K | Hold |
|
|||||
|
2021
Q1 | $257K | Hold |
|
|||||
|
2020
Q4 | $298K | Hold |
|
|||||
|
2020
Q3 | $259K | Sell |
|
|||||
|
2020
Q2 | $510K | Buy |
|
|||||
|
2020
Q1 | $287K | Sell |
|
|||||
|
2019
Q4 | $289K | Hold |
|
|||||
|
2019
Q3 | $230K | Sell |
|
|||||
|
2019
Q2 | $317K | Hold |
|
|||||
|
2019
Q1 | $328K | Buy |
|
|||||
|
2018
Q4 | $302K | Sell |
|
|||||
|
2018
Q3 | $364K | Sell |
|
|||||
|
2018
Q2 | $353K | Buy |
|
|||||
|
2018
Q1 | $288K | Buy |
|
|||||
|
2017
Q4 | $311K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $553K | Buy |
|